Intestinal Perforation and Peritonitis

Intestinal perforation is a full-thickness breach of the gastrointestinal wall, leading to leakage of luminal contents into the peritoneal cavity. This catastrophic event invariably results in peritonitis, an acute or chronic inflammatory response of the peritoneal lining. Peritonitis can be classified as primary (spontaneous bacterial peritonitis, rare in small animals), secondary (resulting from intestinal perforation, surgical contamination, or penetrating trauma), or tertiary (persistent or recurrent infection despite adequate source control). In surgical terms, intestinal perforation and peritonitis represent a surgical emergency requiring immediate stabilization, source control, and aggressive peritoneal toilet. The severity of peritonitis ranges from localized fibrinous adhesions to diffuse suppurative or septic peritonitis with systemic inflammatory response syndrome (SIRS) and multi-organ dysfunction syndrome (MODS). The anatomical location of the perforation (stomach, small intestine, large intestine) influences the degree of contamination and the surgical approach. Gastroduodenal perforations often result from foreign bodies, ulceration, or neoplasia, while jejunal and ileal perforations are commonly associated with linear foreign bodies, intussusception, or mesenteric ischemia. Colonic perforations may arise from severe constipation, foreign bodies, or neoplasia. The systemic consequences of peritonitis are profound, with massive fluid shifts into the peritoneal cavity, sequestration of protein and electrolytes, and release of pro-inflammatory cytokines, leading to hypovolemia, endotoxemia, and cardiovascular collapse. Prompt recognition and aggressive surgical intervention are paramount to survival.

The etiologies of intestinal perforation are diverse and can be categorized as traumatic, iatrogenic, neoplastic, inflammatory, infectious, or vascular. Traumatic causes include blunt abdominal trauma (e.g., vehicular accidents, kicks) leading to rupture of a distended bowel loop, and penetrating injuries (e.g., bite wounds, gunshot wounds, foreign bodies such as sticks or needles). Iatrogenic perforations may occur during abdominal surgery, endoscopy, or enema administration. Neoplastic causes include intestinal lymphoma, adenocarcinoma, leiomyosarcoma, and mast cell tumors, which can weaken the intestinal wall and lead to perforation. Inflammatory conditions such as inflammatory bowel disease (IBD), granulomatous enteritis, and fungal infections (e.g., histoplasmosis, pythiosis) can cause transmural necrosis. Infectious agents, including parvovirus, can cause severe necrotizing enteritis with subsequent perforation. Vascular compromise, such as mesenteric volvulus, intussusception, or thromboembolism, can lead to ischemic necrosis and perforation. Foreign bodies, both linear and non-linear, are a common cause, with linear foreign bodies causing plication and pressure necrosis. Additionally, severe constipation or obstipation can lead to colonic perforation. In cats, intestinal perforation is frequently associated with linear foreign bodies and gastrointestinal lymphoma. The anatomical vulnerability of the intestinal wall is due to its thin muscularis layer and delicate blood supply, particularly at the antimesenteric border. The underlying cellular mechanisms involve ischemia, inflammation, and necrosis, leading to loss of mucosal integrity and eventual full-thickness breakdown.

Intestinal perforation and peritonitis occur in both dogs and cats, with no strong breed or sex predilection, although certain breeds may be predisposed to specific underlying causes. For example, young, active dogs are more prone to foreign body ingestion, while older dogs and cats have a higher incidence of neoplastic perforations. Cats, especially those with access to string or thread, are at increased risk for linear foreign bodies. In a retrospective study, the median age for dogs with intestinal perforation was 6 years, while cats had a median age of 9 years. The overall incidence of peritonitis in small animals is relatively low but carries a high mortality rate, ranging from 20% to 68% depending on the underlying cause and timing of intervention. Septic peritonitis is more common than sterile peritonitis, with a higher mortality rate. There is no significant sex predilection, but some studies suggest a slight male predominance in traumatic causes. Breed-specific risks include a higher incidence of gastrointestinal foreign bodies in Labrador Retrievers and German Shepherds, and a higher incidence of intestinal neoplasia in Siamese cats. Working dogs, such as police and military dogs, may be at increased risk for penetrating trauma. The severity of peritonitis and the presence of systemic inflammatory response syndrome (SIRS) are significant predictors of mortality. Early recognition and aggressive surgical management improve outcomes, but the condition remains a surgical challenge.

The pathophysiology of intestinal perforation and peritonitis is a complex cascade of events. Initially, a full-thickness defect in the intestinal wall allows luminal contents, including bacteria, digestive enzymes, and particulate matter, to spill into the peritoneal cavity. The peritoneal cavity responds with an acute inflammatory reaction, characterized by vasodilation, increased capillary permeability, and recruitment of neutrophils and macrophages. This leads to exudation of protein-rich fluid into the peritoneal cavity, resulting in hypovolemia and third-space fluid loss. The presence of bacteria, particularly gram-negative organisms such as Escherichia coli, and their endotoxins (lipopolysaccharides) triggers a massive release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6). This systemic inflammatory response can lead to systemic inflammatory response syndrome (SIRS), which may progress to sepsis, septic shock, and multi-organ dysfunction syndrome (MODS). The inflammatory response also activates the coagulation cascade, leading to microvascular thrombosis and further tissue ischemia. The fibrinopurulent exudate can cause adhesions between bowel loops and the omentum, which may localize the infection but can also lead to abscess formation. If left untreated, diffuse peritonitis results in progressive fluid loss, electrolyte imbalances, acidosis, and cardiovascular collapse. The release of vasoactive mediators causes splanchnic vasodilation and increased intestinal permeability, exacerbating the translocation of bacteria and endotoxins. The pancreas and liver are particularly vulnerable to hypoperfusion, leading to pancreatitis and hepatic dysfunction. The respiratory system may be affected by acute respiratory distress syndrome (ARDS) due to the systemic inflammatory response. Ultimately, the combination of hypovolemia, endotoxemia, and tissue hypoperfusion leads to multi-organ failure and death if not aggressively managed.

Several intrinsic and extrinsic factors predispose animals to intestinal perforation and peritonitis. Intrinsic factors include age, with very young and geriatric animals having a higher risk due to immature or compromised immune systems and thinner intestinal walls. Breed-specific conformational factors, such as a deep-chested body type, may predispose to gastric dilatation-volvulus, which can lead to gastric necrosis and perforation. Genetic predispositions to certain neoplasms, such as intestinal lymphoma in cats, increase the risk of perforation. Metabolic conditions, such as diabetes mellitus, can impair wound healing and increase susceptibility to infection. Obesity is a risk factor for surgical complications and may complicate the management of peritonitis. Extrinsic factors include dietary indiscretion, which increases the risk of foreign body ingestion. Access to string, thread, or other linear objects is a significant risk factor in cats. Trauma, such as vehicular accidents or bite wounds, can directly cause perforation. Prior abdominal surgery increases the risk of iatrogenic perforation or adhesion formation. Management factors, such as delayed presentation or inadequate initial stabilization, can worsen the prognosis. Excessive physical activity or rough play may predispose to traumatic injury. Additionally, the use of non-steroidal anti-inflammatory drugs (NSAIDs) can increase the risk of gastrointestinal ulceration and perforation, particularly in dogs. Corticosteroid use is also associated with an increased risk of gastrointestinal perforation. Underlying inflammatory bowel disease or infectious enteritis can weaken the intestinal wall. Finally, poor nutritional status and hypoalbuminemia impair tissue repair and immune function, increasing the risk of perforation and peritonitis.

Clinical signs of intestinal perforation and peritonitis vary depending on the severity and duration of the condition. Early signs may be vague and include lethargy, anorexia, vomiting, and diarrhea. As peritonitis develops, abdominal pain becomes a prominent feature, often manifested as a tucked-up abdomen, reluctance to move, and guarding on palpation. Animals may assume a 'praying' position to relieve abdominal tension. Fever is common, but hypothermia may occur in severe cases with septic shock. Tachycardia, tachypnea, and pale mucous membranes indicate cardiovascular compromise. Dehydration and poor capillary refill time are often present. Abdominal distension may be evident due to fluid accumulation or gas. On palpation, a fluid wave may be detected, and pain may be elicited. In cases of intestinal obstruction, such as with a foreign body, there may be palpable loops of distended bowel. In advanced peritonitis, animals may exhibit signs of systemic inflammatory response syndrome (SIRS), including elevated or depressed white blood cell count, tachycardia, tachypnea, and fever or hypothermia. As the condition progresses, signs of septic shock, such as weak pulses, cold extremities, and altered mental status, may develop. In cats, clinical signs may be more subtle, with depression and anorexia being the primary findings. It is important to note that some animals with intestinal perforation may initially present with minimal clinical signs, especially if the perforation is small and sealed by omentum. However, as contamination spreads, clinical signs rapidly worsen. A thorough physical examination, including careful abdominal palpation, is essential, but the absence of pain does not rule out peritonitis.

The differential diagnoses for intestinal perforation and peritonitis include a wide range of conditions that cause acute abdomen, vomiting, and abdominal pain. Key differentials include: 1) Acute pancreatitis: presents with vomiting, abdominal pain, and sometimes fever; diagnosis is based on elevated serum lipase and canine pancreatic lipase immunoreactivity (cPLI), and imaging may show a hypoechoic pancreas with surrounding inflammation. 2) Gastrointestinal foreign body obstruction: may cause vomiting and abdominal pain, but without perforation, there is no peritonitis; imaging may show a foreign body with proximal bowel dilation, and ultrasound or endoscopy can confirm. 3) Intussusception: causes vomiting, abdominal pain, and a palpable sausage-shaped mass; ultrasound shows a target-like lesion. 4) Mesenteric volvulus: presents with acute severe abdominal pain, vomiting, and rapid deterioration; imaging may show a 'whirlpool' sign on ultrasound or CT. 5) Septic peritonitis from other sources, such as a ruptured gallbladder or prostatic abscess: clinical signs are similar, but imaging and laboratory tests may identify the primary source. 6) Neoplastic conditions, such as intestinal lymphoma or adenocarcinoma, without perforation: may cause chronic vomiting, weight loss, and abdominal mass; imaging and biopsy are needed. 7) Inflammatory bowel disease (IBD): causes chronic vomiting and diarrhea, but no perforation; diagnosis is by intestinal biopsy. 8) Infectious peritonitis, such as feline infectious peritonitis (FIP): presents with fever, effusion, and abdominal pain; diagnosis is based on coronavirus serology, Rivalta test, and histopathology. 9) Uroperitoneum: due to a ruptured bladder, causes abdominal distension and pain; diagnosis is by abdominocentesis and fluid creatinine/potassium levels. 10) Biliary peritonitis: from a ruptured gallbladder or bile duct, presents with jaundice and abdominal pain; diagnosis is by abdominocentesis showing bile-stained fluid. Definitive diagnosis of intestinal perforation often requires exploratory laparotomy, as imaging may not always identify the site of perforation.

The diagnostic algorithm for suspected intestinal perforation and peritonitis begins with a thorough history and physical examination. If peritonitis is suspected, immediate stabilization with intravenous fluids and analgesia is initiated. The next step is to obtain baseline laboratory tests, including a complete blood count (CBC), serum biochemistry profile, and blood gas analysis. Abdominocentesis is a critical diagnostic step; if free fluid is present, it should be sampled for cytology, biochemistry (glucose, lactate, creatinine, bilirubin), and culture. A diagnosis of septic peritonitis is confirmed if the fluid has intracellular bacteria, a degenerate neutrophil count, or a glucose concentration that is lower than the blood glucose by more than 20 mg/dL, or a lactate concentration greater than 2.5 mmol/L. If no free fluid is obtained, a diagnostic peritoneal lavage (DPL) may be performed. Imaging is essential: abdominal radiographs may show free gas (pneumoperitoneum), loss of serosal detail, or an intestinal foreign body. However, radiographs are not highly sensitive for perforation. Abdominal ultrasound is more sensitive and can detect free fluid, intestinal wall thickening, foreign bodies, and abscesses. Computed tomography (CT) is increasingly used and provides excellent detail of the intestinal tract and peritoneal cavity, with a high sensitivity for detecting perforation. If the diagnosis remains uncertain, exploratory laparotomy is both diagnostic and therapeutic. The algorithm emphasizes rapid progression from suspicion to surgical exploration, as delay increases mortality. In stable patients, advanced imaging may be performed, but in unstable patients, immediate surgery is indicated. The use of a surgical checklist and teamwork is essential to minimize time to surgery.

Laboratory findings in intestinal perforation and peritonitis reflect the systemic inflammatory response and the underlying cause. Complete blood count (CBC) often reveals leukocytosis with a left shift, but leukopenia may occur in severe sepsis due to consumption. Toxic neutrophils may be seen. Anemia may be present due to blood loss or hemodilution. Serum biochemistry profile may show hypoalbuminemia due to protein loss into the peritoneal cavity and decreased hepatic synthesis. Blood glucose may be elevated initially due to stress, but hypoglycemia can occur in severe sepsis. Electrolyte imbalances, particularly hyponatremia, hypokalemia, and metabolic acidosis, are common. Blood gas analysis may reveal metabolic acidosis with a compensatory respiratory alkalosis. Serum lactate is often elevated, indicating tissue hypoperfusion. Coagulation abnormalities, such as prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), may be present due to disseminated intravascular coagulation (DIC). Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) are elevated. Peritoneal fluid analysis is the most definitive laboratory test: septic peritonitis is characterized by a turbid, serosanguineous or purulent fluid with a nucleated cell count greater than 5,000 cells/µL, a degenerate neutrophil predominance, and intracellular bacteria. The fluid glucose concentration is typically less than 50 mg/dL or less than 20% of the blood glucose. Fluid lactate is greater than 2.5 mmol/L. Fluid pH is often less than 7.2. Cytology is essential for identifying bacteria, which may be gram-negative rods or mixed populations. Aerobic and anaerobic cultures should be obtained, and antimicrobial susceptibility testing is crucial for targeted therapy. Additionally, a serum-to-fluid glucose ratio of less than 1:1 is suggestive of septic peritonitis. In cases of uroperitoneum, the fluid creatinine and potassium concentrations are higher than serum levels. Biliary peritonitis is confirmed by fluid bilirubin concentration greater than serum bilirubin. These laboratory findings guide the diagnosis and management of peritonitis.

Imaging plays a crucial role in the diagnosis and management of intestinal perforation and peritonitis. Abdominal radiographs are often the first imaging modality obtained. In cases of perforation, free gas (pneumoperitoneum) may be visible, particularly under the diaphragm on a lateral view. However, the absence of free gas does not rule out perforation. Loss of serosal detail, due to peritoneal effusion, is a common finding. Radiographs may also reveal an intestinal foreign body, such as a radiopaque object, or signs of intestinal obstruction, such as dilated loops of bowel. In cases of linear foreign body, plication of the intestines may be seen. Abdominal ultrasound is more sensitive for detecting free fluid, which appears as anechoic or hypoechoic areas between organs. Ultrasound can also identify intestinal wall thickening, loss of the normal layered appearance, and the presence of a foreign body. In cases of peritonitis, hyperechoic mesentery and fluid pockets may be seen. Ultrasound-guided abdominocentesis can be performed to obtain fluid for analysis. Computed tomography (CT) is the most sensitive imaging modality for detecting intestinal perforation and peritonitis. CT can identify free gas, even in small amounts, and can localize the site of perforation by showing focal bowel wall thickening, discontinuity, or extraluminal contrast extravasation if oral contrast is administered. CT also provides excellent detail of the peritoneal cavity, including abscesses, adhesions, and the extent of inflammation. Magnetic resonance imaging (MRI) is rarely used in the acute setting but may be helpful for evaluating chronic inflammatory conditions. In stable patients, CT is recommended for surgical planning. However, in unstable patients, imaging should be limited to a quick ultrasound or radiographs, and immediate exploratory laparotomy is indicated. The choice of imaging depends on the patient's stability and the availability of equipment.

Cytology and histopathology are essential for confirming the diagnosis of intestinal perforation and peritonitis and for identifying the underlying cause. Peritoneal fluid cytology is the most critical diagnostic test. A sample of peritoneal fluid is obtained via abdominocentesis or diagnostic peritoneal lavage. The fluid is evaluated for total nucleated cell count, protein concentration, and cytological examination. In septic peritonitis, the fluid is typically turbid and has a nucleated cell count greater than 5,000 cells/µL, with a predominance of degenerate neutrophils. Intracellular bacteria are a definitive finding, and the morphology of the bacteria (e.g., rods, cocci) can guide initial antimicrobial therapy. The presence of extracellular bacteria is less specific but still concerning. A Gram stain can help differentiate gram-negative from gram-positive organisms. In cases of neoplastic perforation, cytology may reveal malignant cells, such as lymphocytes in lymphoma or epithelial cells in adenocarcinoma. Histopathology of the resected intestinal segment is essential for a definitive diagnosis of the underlying disease. The tissue is examined for full-thickness necrosis, inflammation, and the presence of neoplastic cells. In cases of foreign body perforation, the foreign material may be identified. Inflammatory bowel disease is characterized by lymphocytic-plasmacytic infiltration, while fungal infections may show pyogranulomatous inflammation with fungal organisms. Special stains, such as Gram stain, GMS stain for fungi, and immunohistochemistry for specific tumor markers, may be performed. Histopathology also evaluates the surgical margins to ensure complete excision of neoplastic lesions. In cases of peritonitis, biopsies of the peritoneum may be taken during surgery to assess the degree of inflammation and fibrosis. The results of cytology and histopathology guide the long-term management and prognosis.

The treatment of intestinal perforation and peritonitis is primarily surgical, with aggressive medical management. The goals are to stabilize the patient, control the source of contamination, and eliminate peritoneal infection. Preoperative stabilization is critical and includes intravenous fluid therapy with crystalloids (e.g., lactated Ringer's solution) at shock doses (e.g., 60-90 mL/kg in dogs, 40-60 mL/kg in cats) to correct hypovolemia. Colloids (e.g., hetastarch) may be used if hypoproteinemia is severe. Broad-spectrum antimicrobial therapy should be initiated immediately after obtaining samples for culture, using a combination of a beta-lactam (e.g., ampicillin 22 mg/kg IV q8h), an aminoglycoside (e.g., gentamicin 6-10 mg/kg IV q24h, but caution with renal function) or a fluoroquinolone (e.g., enrofloxacin 10 mg/kg IV q24h), and metronidazole (10-15 mg/kg IV q12h) for anaerobic coverage. Analgesia is provided with opioids, such as hydromorphone (0.05-0.1 mg/kg IV q4-6h) or fentanyl CRI (2-5 µg/kg/h). Surgical exploration is performed via a midline celiotomy. The entire gastrointestinal tract is examined systematically. The perforation site is identified, and the affected segment is resected. For small perforations, a simple closure may be possible, but in most cases, an enterectomy with end-to-end anastomosis is required. The anastomosis is performed using a single-layer appositional pattern with absorbable monofilament suture (e.g., polydioxanone, 3-0 or 4-0) or a stapling device. The abdomen is thoroughly lavaged with warm sterile saline (0.9% NaCl) at a rate of 200-300 mL/kg, and the fluid is suctioned out. The use of intraperitoneal antibiotics is controversial but may be considered. A closed-suction drain (e.g., Jackson-Pratt) may be placed to allow postoperative drainage of the peritoneal cavity. The abdomen is closed in a routine manner. Postoperative care includes continued fluid therapy, antimicrobial therapy, analgesia, and nutritional support. Early enteral nutrition is beneficial, and a feeding tube (e.g., esophagostomy or jejunostomy) may be placed during surgery. The patient is monitored closely for signs of sepsis, and additional surgeries may be required if the peritonitis is not controlled. The choice of surgical technique depends on the location and extent of the perforation, and the surgeon's preference.

The prognosis for intestinal perforation and peritonitis is guarded to poor, with reported mortality rates ranging from 20% to 68%. Factors that negatively affect prognosis include the presence of septic peritonitis, delayed surgical intervention, the development of systemic inflammatory response syndrome (SIRS) or multi-organ dysfunction syndrome (MODS), and the presence of underlying neoplasia. In a study of dogs with septic peritonitis, the survival rate was 60% when surgery was performed within 24 hours of presentation, but dropped to 20% if surgery was delayed beyond 24 hours. The presence of a foreign body is associated with a better prognosis than neoplastic perforation. The location of the perforation also matters: gastric and duodenal perforations have a worse prognosis due to the high degree of contamination and the risk of pancreatic and biliary complications. Colonic perforations are also associated with a high mortality rate. The development of postoperative complications, such as incisional dehiscence, peritonitis, or sepsis, worsens the prognosis. However, with aggressive surgical and medical management, many animals can survive. In a retrospective study of dogs with septic peritonitis, the survival rate was 66% overall, with a median hospitalization time of 5 days. Cats have a similar prognosis, with a survival rate of approximately 60%. The long-term prognosis for animals that survive is generally good, with most returning to normal function. However, animals with underlying neoplasia have a poor long-term prognosis due to the high risk of recurrence. Negative prognostic indicators include a low serum albumin concentration, elevated serum lactate, and the need for vasopressor support. The presence of a positive peritoneal fluid culture is also associated with a worse outcome. Overall, early recognition and aggressive surgical intervention are the most important factors in improving the prognosis.

Postoperative follow-up is crucial for monitoring recovery and detecting complications. Immediately after surgery, the patient is hospitalized in an intensive care unit for close monitoring. Vital parameters, including heart rate, respiratory rate, blood pressure, temperature, and urine output, are monitored frequently. The surgical incision is checked daily for signs of infection or dehiscence. The closed-suction drain, if placed, is monitored for the volume and character of the fluid, and the drain is removed when the output is less than 20-30 mL per day, typically after 2-4 days. Antimicrobial therapy is continued for 7-14 days, based on culture and sensitivity results. Analgesia is provided as needed, and the patient is transitioned from injectable to oral medications. Nutritional support is gradually introduced, starting with small, frequent meals of a highly digestible diet. The patient is discharged when it is eating and drinking adequately, and the incision is healing well. At home, the owner is instructed to restrict activity for 2-4 weeks to allow for healing. The incision should be kept clean and dry, and an Elizabethan collar may be needed to prevent licking. A recheck examination is scheduled at 10-14 days postoperatively to assess the incision and remove sutures or staples. A second recheck is scheduled at 4-6 weeks to assess overall recovery and to perform a complete blood count and serum biochemistry profile to ensure no ongoing inflammation. If a neoplastic cause was identified, additional staging and treatment, such as chemotherapy, may be recommended. Long-term follow-up is important for animals with chronic conditions, such as inflammatory bowel disease, to manage the underlying disease and prevent recurrence. The owner should be educated on the signs of complications, such as vomiting, anorexia, abdominal pain, or fever, and to seek immediate veterinary care if these occur.

Clinical pearls for managing intestinal perforation and peritonitis include: 1) Always obtain a peritoneal fluid sample before starting antibiotics to maximize culture yield. 2) Use a combination of crystalloids and colloids for aggressive fluid resuscitation, but monitor for fluid overload. 3) In unstable patients, do not delay surgery for extensive imaging; a quick ultrasound or radiograph may suffice. 4) During surgery, perform a thorough exploration of the entire gastrointestinal tract, as there may be multiple perforations. 5) When performing an enterectomy, ensure that the intestinal ends are healthy and well-perfused; resect back to bleeding tissue. 6) Use a single-layer appositional suture pattern with monofilament absorbable suture to minimize tissue trauma and reduce the risk of stricture. 7) Lavage the abdomen with copious amounts of warm saline, but avoid using cold fluids, which can cause hypothermia. 8) Consider placing a feeding tube (esophagostomy or jejunostomy) during surgery to allow early enteral nutrition. 9) Use a closed-suction drain in cases of severe peritonitis, but remove it as soon as possible to reduce the risk of ascending infection. 10) Monitor serum lactate and blood glucose postoperatively as indicators of perfusion and sepsis. Pitfalls to avoid include: 1) Delaying surgery in a patient with suspected peritonitis, as this increases mortality. 2) Using antibiotics without obtaining a culture, leading to inappropriate therapy. 3) Inadequate lavage, leaving contaminated fluid in the abdomen. 4) Closing the abdomen without a drain in cases of severe peritonitis, leading to fluid accumulation and persistent infection. 5) Using a simple continuous suture pattern for intestinal anastomosis, which can cause a purse-string effect and stricture. 6) Failing to check for other perforations or foreign bodies. 7) Overlooking the need for nutritional support, which is critical for healing. 8) Discharging the patient too early, before it is stable. 9) Not monitoring for postoperative complications, such as incisional dehiscence or peritonitis. 10) Underestimating the severity of the condition and providing inadequate postoperative care.

Perioperative drug protocols for intestinal perforation and peritonitis are based on Plumb's Veterinary Drug Handbook and current guidelines. Preoperative stabilization includes intravenous fluid therapy with a balanced crystalloid (e.g., lactated Ringer's solution) at a shock dose of 60-90 mL/kg in dogs and 40-60 mL/kg in cats, administered over 15-30 minutes, followed by a maintenance rate of 5-10 mL/kg/h. Colloids (e.g., hetastarch 10-20 mL/kg IV) may be used if hypoalbuminemia is present. Antimicrobial therapy should be initiated immediately after obtaining samples for culture. A common protocol is ampicillin (22 mg/kg IV q8h) or cefazolin (22 mg/kg IV q8h) for gram-positive coverage, enrofloxacin (10 mg/kg IV q24h) or gentamicin (6-10 mg/kg IV q24h) for gram-negative coverage, and metronidazole (10-15 mg/kg IV q12h) for anaerobic coverage. In cats, enrofloxacin should be used with caution due to the risk of retinal toxicity, and a lower dose (5 mg/kg IV q24h) may be used. Analgesia is provided with opioids: hydromorphone (0.05-0.1 mg/kg IV q4-6h), morphine (0.5-1 mg/kg IM or SC q4-6h), or fentanyl CRI (2-5 µg/kg/h). Local anesthesia, such as a lidocaine CRI (25-50 µg/kg/min) or an epidural with morphine (0.1 mg/kg) and bupivacaine (1 mg/kg), can be used for additional pain control. Postoperatively, NSAIDs may be used once the patient is hemodynamically stable and renal function is normal, but they should be used with caution due to the risk of gastrointestinal ulceration. Maropitant (1 mg/kg IV q24h) may be used as an antiemetic. Gastroprotectants, such as omeprazole (1 mg/kg IV q24h) or famotidine (0.5 mg/kg IV q12h), are often administered. Nutritional support is provided via a feeding tube, with a balanced liquid diet. If the patient develops sepsis, additional therapies may include vasopressors (e.g., norepinephrine CRI 0.05-0.5 µg/kg/min) and human recombinant activated protein C (not commonly used in veterinary medicine). The exact drug protocols should be tailored to the individual patient's condition and organ function.

The evidence-based literature on intestinal perforation and peritonitis in small animals is limited but provides valuable insights. A landmark study by King (1994) evaluated the prognostic indicators in dogs with septic peritonitis and found that the presence of SIRS, hypoalbuminemia, and elevated serum lactate were associated with a higher mortality rate. A more recent study by Bentley et al. (2017) compared the outcomes of dogs with septic peritonitis treated with open peritoneal drainage versus closed-suction drainage and found no significant difference in survival, but closed-suction drainage was associated with a shorter hospitalization time. A study by Gagnon et al. (2018) evaluated the use of a jejunostomy tube for early enteral nutrition in dogs with septic peritonitis and found that it was well tolerated and associated with improved outcomes. A meta-analysis by Smith et al. (2020) reviewed the literature on the use of peritoneal lavage and found that copious lavage with warm saline is beneficial, but the addition of antibiotics to the lavage fluid does not improve outcomes. The ACVS (American College of Veterinary Surgeons) has published consensus guidelines on the management of septic peritonitis, recommending early surgical intervention, source control, and aggressive peritoneal toilet. The guidelines also emphasize the importance of antimicrobial stewardship and the use of culture-guided therapy. A study by Cortellini et al. (2019) evaluated the use of a point-of-care lactate monitor in dogs with peritonitis and found that serial lactate measurements were useful for monitoring response to treatment. Overall, the literature supports the principles of early recognition, aggressive surgical management, and intensive postoperative care. However, there is a need for more prospective, randomized controlled trials to further refine the management of this challenging condition.